Close X
Saturday, September 21, 2024
ADVT 
International

US Mission in India processes over 1 mn non-immigrant visas in 2023

Darpan News Desk IANS, 28 Sep, 2023 10:48 AM
  • US Mission in India processes over 1 mn non-immigrant visas in 2023

New Delhi, Sep 28 (IANS): The US Mission to India said on Thursday that it has reached and surpassed its goal to process one million non-immigrant visa applications in 2023.

Stating that Indians made over one in 10 visa applications worldwide, the Mission said it has already surpassed the total number of cases processed in 2022 and is processing almost 20 per cent more applications than in pre-pandemic 2019.

“Our partnership with India is one of the United States’ most important bilateral relationships, and in fact one of the most important relationships in the world," US Ambassador to India Eric Garcetti said.

"The ties between our people are stronger than ever, and we will continue our record-setting volume of visa work in the coming months to give as many Indian applicants as possible the opportunity to travel to the United States and experience the US-India friendship firsthand,” Garcetti added.

The Ambassador on Thursday handed over the passport to the one millionth visa holder and said: “… this year we are so proud… we have processed over 1 million visa applications."

Last year ,over 1.2 million Indians visited the US, making this one of the most robust travel relationships in the world.

Indians now represent over 10 per cent of all visa applicants worldwide, including 20 per cent of all student visa applicants and 65 per cent of all H&L-category (employment) visa applicants.

Recognising the continued high demand for its visas, the Mission said that the US continues to invest heavily in our operations in India.

In the past year, the Mission said it expanded its staffing to facilitate more visa processing, and made significant capital improvements to existing facilities, such as the US Consulate in Chennai, and inaugurating a new Consulate building in Hyderabad.

The Mission said that beginning next year, it plans to implement a pilot program that would allow domestic visa renewal for qualified H&L-category employment visa applicants.

MORE International ARTICLES

Texas massacre exposes painful American divide

Texas massacre exposes painful American divide
Act 1 came Tuesday, when an 18-year-old gunman, armed with an AR-15 semi-automatic rifle, killed 19 pre-teen children and two teachers in a fourth-grade classroom before dying himself at the hands of law enforcement.

Texas massacre exposes painful American divide

Texas governor: 15 killed in school shooting; gunman dead

Texas governor: 15 killed in school shooting; gunman dead
An 18-year-old gunman opened fire Tuesday at a Texas elementary school, killing 14 children, one teacher and injuring others, Gov. Greg Abbott said, and the gunman was dead. It was the deadliest shooting at a U.S. grade school since the shocking attack in Sandy Hook, Connecticut, almost a decade ago.

Texas governor: 15 killed in school shooting; gunman dead

African scientists baffled by monkeypox cases in Europe, US

African scientists baffled by monkeypox cases in Europe, US
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. 

African scientists baffled by monkeypox cases in Europe, US

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill